{"gene":"AVPR2","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":1992,"finding":"Mutations in AVPR2 (the vasopressin V2 receptor gene at Xq28) cause X-linked nephrogenic diabetes insipidus (NDI), establishing AVPR2 as the gene responsible for renal insensitivity to vasopressin; point mutations resulting in non-conservative amino acid substitutions co-segregated with NDI in affected families.","method":"DNA sequencing of AVPR2 in NDI probands; co-segregation analysis in families","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — foundational disease-gene identification replicated across multiple independent labs and hundreds of families","pmids":["1303271"],"is_preprint":false},{"year":2001,"finding":"Calnexin, an ER chaperone, associates with both wild-type AVPR2 and NDI-causing mutant receptors (W71X, R337X) during folding; ER-retained mutant R337X showed prolonged calnexin association compared to wild-type, indicating calnexin participates in quality control and ER retention of misfolded AVPR2.","method":"Sequential co-immunoprecipitation, immunofluorescence/confocal microscopy, Western blot, RT-PCR, metabolic labeling in transfected cells","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus localization with functional consequence, multiple orthogonal methods in one study","pmids":["11389590"],"is_preprint":false},{"year":1997,"finding":"The NDI-associated truncation mutant V2R-R337ter fails to reach the plasma membrane because it is retained as an ER precursor form (endoglycosidase H-sensitive); minimum protein length including residues up to position 341 (and the identity of residue 340) is required for V2R to undergo maturation, acquire cell-surface expression, bind ligand, and couple to adenylyl cyclase.","method":"ELISA on epitope-tagged surface receptors, endoglycosidase H treatment, metabolic labeling, adenylyl cyclase activity assay, binding assay in COS.M6/HEK293 cells","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro functional assays plus glycosylation maturation analysis; rigorous mechanistic dissection with multiple truncation constructs","pmids":["9171234"],"is_preprint":false},{"year":2006,"finding":"After vasopressin stimulation of renal epithelial cells, V2R is rapidly internalized into endosomes while AQP2 remains at the cell surface in 'endocytosis-resistant' membrane domains; V2R endocytosis is independent of cAMP elevation (forskolin does not induce it), and apical vasopressin can induce basolateral V2R down-regulation and vice versa.","method":"Confocal live-cell imaging of epitope-tagged V2R and AQP2 in LLC-PK1 cells, fluid-phase endocytosis marker (FITC-dextran) co-localization, polarized cell filter assays","journal":"Biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — direct localization with functional consequence; multiple orthogonal imaging and pharmacological approaches","pmids":["16563128"],"is_preprint":false},{"year":2007,"finding":"Alix (AIP1) interacts with the last 29 amino acids of the V2R C-terminus and increases lysosomal (not proteasomal) degradation of V2R after vasopressin stimulation; overexpression of Alix virtually eliminates V2R-GFP fluorescence within 2 h of vasopressin exposure, an effect blocked by chloroquine but not MG132.","method":"Yeast two-hybrid screening, GST pull-down assay, immunolocalization, transfection of Alix into LLC-PK1/V2R-GFP cells, Western blotting with chloroquine/MG132 inhibitors","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 — yeast two-hybrid confirmed by pull-down and functional cell assay with pathway-specific inhibitors","pmids":["17287200"],"is_preprint":false},{"year":2008,"finding":"Vasopressin reduces LPS-induced pulmonary inflammation (IL-6 levels and NF-κB/phospho-IκB) through the V2R; pretreatment with a V2R-specific antagonist completely abolished vasopressin's immunosuppressive pulmonary effects, placing V2R in an anti-inflammatory signaling pathway in the lung.","method":"In vivo mouse sepsis model (LPS), vasopressin infusion with receptor-subtype-selective antagonist pretreatment, immunoblotting for phospho-IκB, ELISA for IL-6","journal":"Resuscitation","confidence":"Medium","confidence_rationale":"Tier 2 — clean pharmacological epistasis with selective antagonist in vivo; single study","pmids":["18951114"],"is_preprint":false},{"year":2008,"finding":"V2R promoter activity is upregulated by hypertonicity via JNK and PKA pathways (10-bp Sp1 motif is the responsive element), and suppressed by V1aR stimulation through a Ca2+ pathway that is further enhanced under hypertonic conditions, demonstrating reciprocal transcriptional regulation between V1aR and V2R signaling.","method":"Promoter-reporter assays in LLC-PK1/rV1aR cells, JNK inhibitor (SP600125) and PKA inhibitor (H89) pharmacology, intracellular Ca2+ measurements, deletion analysis of promoter","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — promoter-reporter with mutagenesis and kinase inhibitors; single lab study","pmids":["18701631"],"is_preprint":false},{"year":2011,"finding":"Non-peptide V2R antagonists (OPC41061, OPC31260) act as protean agonists: they serve as pharmacological chaperones that rescue membrane trafficking of inactivating V2R mutants (Ser-333del, Y128S) while acting as inverse agonists of wild-type receptor; the trafficking defect of these mutants is not corrected by inhibiting internalization alone.","method":"cAMP accumulation assay, immunofluorescence localization in COS-7 cells, pharmacological chaperone rescue experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — functional cAMP assay plus localization rescue in cell culture; single study","pmids":["22144672"],"is_preprint":false},{"year":2015,"finding":"A novel I130N gain-of-function AVPR2 mutation causes constitutive (ligand-independent) cAMP production and constitutive dynamin-dependent, β-arrestin-independent internalization of V2R; agonist-induced endocytosis remained β-arrestin-dependent, revealing mechanistically distinct modes of constitutive vs. agonist-stimulated V2R internalization.","method":"cAMP assay in HEK293 cells, dominant-negative dynamin rescue of surface expression, β-arrestin interaction assays, tolvaptan (inverse agonist) inhibition of basal cAMP","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal functional assays (cAMP, internalization, dominant-negative rescue) in single study","pmids":["26131744"],"is_preprint":false},{"year":2021,"finding":"Crystal structures of arrestin-2 in complex with four different phosphopeptides derived from the V2R C-tail reveal that individual phosphorylation sites allosterically influence arrestin conformation at remote sites; an interdependent phospho-binding mechanism exists between different arrestin phospho-interaction sites, and specific phosphorylation patterns bias arrestin structural states that correlate with selective arrestin functions.","method":"X-ray crystallography (four structures), FRET, 1H NMR with genetic code expansion in arrestin-2/V2R phosphopeptide complexes","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — crystal structures validated by FRET and NMR; multiple orthogonal methods in one study","pmids":["33888704"],"is_preprint":false},{"year":2024,"finding":"The V2R–β-arrestin complex scaffolds Gβγ at the plasma membrane through a direct β-arrestin–Gβγ interaction and transports Gβγ to endosomes, where Gβγ potentiates Gαs endosomal translocation, thereby regenerating an endosomal pool of heterotrimeric Gs and enabling sustained endosomal G protein signaling.","method":"Co-IP/pulldown demonstrating β-arrestin–Gβγ interaction, live-cell imaging of V2R, β-arrestin, and G protein subunit translocation, functional endosomal cAMP signaling assays","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct protein interaction plus functional endosomal signaling; single study with multiple complementary approaches","pmids":["38972875"],"is_preprint":false},{"year":2012,"finding":"dDAVP conjugated to nine D-arginines (dDAVP-9r) binds V2R on inner medullary collecting duct (IMCD) cells and mediates receptor-dependent internalization to deliver siRNA intracellularly; siRNA delivery was specific to V2R-expressing cells and not observed in V2R-negative COS-7 cells, and induced AQP2 phosphorylation at Ser256.","method":"siRNA polyplex formation assay, fluorescence microscopy in MDCK/LLC-PK1/COS-7 cells, AQP2 knockdown by Western blot, AQP2 phosphorylation assay in primary IMCD cells","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — receptor-dependent delivery demonstrated by V2R-negative cell controls and functional knockdown; single study","pmids":["22761946"],"is_preprint":false},{"year":2000,"finding":"The NDI-causing AVPR2 mutation A84D (near conserved D85) causes intracellular retention of the receptor and severely impairs both ligand binding and G protein coupling, while W99R (first extracellular loop) mainly impairs ligand binding with minor effect on intracellular routing, revealing residue-specific contributions to V2R folding vs. ligand recognition.","method":"Radioligand binding assay, adenylyl cyclase coupling assay, immunofluorescence localization in transfected cells","journal":"Journal of the American Society of Nephrology : JASN","confidence":"Medium","confidence_rationale":"Tier 2 — binding and coupling assays plus localization; single study with two mutants dissecting distinct functional domains","pmids":["10820167"],"is_preprint":false},{"year":2020,"finding":"Five NDI-causing AVPR2 mutations were functionally characterized: R113Q and C192S localize normally to the basolateral membrane with mature glycosylation; L86P, M272R, and W323_I324insR are retained in the ER with immature glycosylation and reduced stability. Tolvaptan (V2R antagonist/pharmacochaperone) rescued M272R by restoring glycosylation maturation, membrane sorting, and cAMP response to dDAVP.","method":"Immunofluorescence localization in polarized MDCK cells, glycosylation maturation (Endo H assay), cAMP release assay, tolvaptan pharmacochaperone rescue","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical and cell biological assays with pharmacochaperone rescue; single study","pmids":["33009446"],"is_preprint":false}],"current_model":"AVPR2 (the renal vasopressin V2 receptor) is a G protein-coupled receptor that, upon vasopressin binding, activates Gαs/adenylyl cyclase/cAMP signaling to drive AQP2 trafficking to the apical membrane; ER chaperone calnexin assists V2R folding and performs quality control on misfolded mutants, Alix promotes lysosomal V2R degradation after ligand-stimulated internalization, β-arrestin scaffolds Gβγ to enable endosomal G protein signaling, and the phosphorylation pattern of the V2R C-tail allosterically determines arrestin conformation and selective downstream functions, while gain-of-function mutations cause constitutive cAMP production and β-arrestin-independent internalization leading to inappropriate antidiuresis."},"narrative":{"teleology":[{"year":1992,"claim":"Identification of AVPR2 as the causative gene for X-linked nephrogenic diabetes insipidus established the molecular basis of renal vasopressin resistance, linking a specific GPCR to water homeostasis.","evidence":"DNA sequencing and co-segregation analysis in NDI families","pmids":["1303271"],"confidence":"High","gaps":["Mechanism by which individual mutations impair receptor function was unknown","No structure–function dissection of critical residues"]},{"year":1997,"claim":"Demonstrating that the NDI truncation mutant R337ter is retained in the ER as an immature glycoform incapable of ligand binding or adenylyl cyclase coupling established that the C-terminal tail is essential for V2R maturation and surface trafficking.","evidence":"Endoglycosidase H sensitivity, surface ELISA, adenylyl cyclase assay, and truncation series in COS.M6/HEK293 cells","pmids":["9171234"],"confidence":"High","gaps":["Identity of chaperones involved in ER retention unknown","Structural basis of C-tail requirement unresolved"]},{"year":2000,"claim":"Functional dissection of A84D and W99R mutations revealed that specific residues contribute to distinct steps — protein folding/routing versus ligand recognition — showing that NDI mutations do not act through a single mechanism.","evidence":"Radioligand binding, adenylyl cyclase coupling, and immunofluorescence in transfected cells","pmids":["10820167"],"confidence":"Medium","gaps":["Only two mutants examined","No structural context for folding versus binding defects"]},{"year":2001,"claim":"Identifying calnexin as an ER chaperone that associates with both wild-type and misfolded V2R — with prolonged association for ER-retained mutants — established the molecular basis for ER quality control of V2R.","evidence":"Sequential co-immunoprecipitation, confocal microscopy, and metabolic labeling in transfected cells","pmids":["11389590"],"confidence":"High","gaps":["Whether calnexin is sufficient or necessary for retention unknown","Role of other ER quality control components not addressed"]},{"year":2006,"claim":"Live-cell imaging revealed that after vasopressin stimulation V2R is rapidly internalized while AQP2 remains at the surface in endocytosis-resistant domains, demonstrating that V2R signaling and V2R endocytosis are temporally uncoupled from the effector (AQP2) response.","evidence":"Confocal live-cell imaging with epitope-tagged V2R and AQP2 in polarized LLC-PK1 cells","pmids":["16563128"],"confidence":"High","gaps":["Molecular identity of 'endocytosis-resistant' AQP2 domains unclear","Mechanism coupling basolateral V2R internalization to apical AQP2 not defined"]},{"year":2007,"claim":"Discovery that Alix binds the V2R C-terminus and promotes lysosomal rather than proteasomal degradation after vasopressin stimulation defined the post-endocytic sorting route that terminates V2R signaling.","evidence":"Yeast two-hybrid, GST pull-down, and lysosomal/proteasomal inhibitor experiments in LLC-PK1 cells","pmids":["17287200"],"confidence":"High","gaps":["ESCRT-pathway components downstream of Alix not mapped","Stoichiometry and regulation of Alix–V2R interaction unknown"]},{"year":2008,"claim":"Reciprocal transcriptional regulation of AVPR2 by hypertonicity (via JNK/PKA) and V1aR signaling (via Ca²⁺) through a 10-bp Sp1 element revealed how extracellular tonicity and receptor cross-talk control V2R expression levels.","evidence":"Promoter-reporter deletion analysis and kinase inhibitors in LLC-PK1 cells","pmids":["18701631"],"confidence":"Medium","gaps":["In vivo relevance of V1aR-V2R transcriptional cross-talk unverified","Whether Sp1 itself is the transcription factor binding this element not confirmed by direct binding assay"]},{"year":2011,"claim":"Showing that non-peptide V2R antagonists rescue surface trafficking of ER-retained NDI mutants while acting as inverse agonists on wild-type receptor established the pharmacological chaperone concept for V2R and its therapeutic potential in NDI.","evidence":"cAMP accumulation assay and immunofluorescence rescue in COS-7 cells with OPC41061/OPC31260","pmids":["22144672"],"confidence":"Medium","gaps":["No in vivo pharmacochaperone rescue demonstrated in this study","Structural basis for chaperone versus inverse agonist activity unclear"]},{"year":2015,"claim":"The gain-of-function I130N mutation revealed that constitutive V2R internalization occurs through a dynamin-dependent but β-arrestin-independent pathway, mechanistically distinct from agonist-stimulated β-arrestin-dependent endocytosis.","evidence":"cAMP assay, dominant-negative dynamin, β-arrestin interaction assays in HEK293 cells","pmids":["26131744"],"confidence":"Medium","gaps":["Adaptor mediating constitutive β-arrestin-independent internalization not identified","Only one gain-of-function mutation studied"]},{"year":2020,"claim":"Systematic functional characterization of five NDI mutations in polarized cells, including pharmacochaperone rescue of M272R by tolvaptan, confirmed that ER-retained V2R mutants can be functionally rescued to restore both surface expression and cAMP signaling.","evidence":"Endo H glycosylation assay, immunofluorescence in polarized MDCK cells, cAMP assay with tolvaptan rescue","pmids":["33009446"],"confidence":"Medium","gaps":["Clinical efficacy of pharmacochaperone therapy not demonstrated","Rescue of R113Q and C192S (surface-expressed but non-functional) not achieved"]},{"year":2021,"claim":"Crystal structures of arrestin-2 with four distinct V2R C-tail phosphopeptides revealed that specific phosphorylation patterns allosterically determine arrestin conformation at remote sites, providing the structural basis for phosphorylation-barcode-dependent biased signaling.","evidence":"X-ray crystallography of four arrestin-2/V2Rpp complexes validated by FRET and ¹H NMR","pmids":["33888704"],"confidence":"High","gaps":["Full-length V2R–arrestin complex structure not determined","Cellular phosphorylation dynamics at individual sites in native tissue not mapped"]},{"year":2024,"claim":"Demonstration that the V2R–β-arrestin complex scaffolds Gβγ and transports it to endosomes to regenerate heterotrimeric Gs established a mechanism for sustained endosomal G protein signaling, resolving how V2R continues cAMP production after internalization.","evidence":"Co-IP/pulldown of β-arrestin–Gβγ, live-cell imaging of G protein translocation, endosomal cAMP assays","pmids":["38972875"],"confidence":"Medium","gaps":["Relative contribution of endosomal versus plasma membrane signaling to physiological water reabsorption not quantified","Whether this mechanism operates in collecting duct cells in vivo not shown"]},{"year":null,"claim":"A full-length V2R–Gs–β-arrestin megacomplex structure and in vivo quantification of endosomal versus plasma membrane cAMP contributions to the antidiuretic response remain unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No full-length receptor–arrestin–G protein ternary complex structure exists","In vivo pharmacochaperone efficacy for NDI mutants unestablished in clinical trials driven by structural insights","Native phosphorylation barcode kinetics on V2R in renal tissue not characterized"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,2,3,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[9,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,3,13]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,2,13]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[3,10]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,8,9,10]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,7,13]}],"complexes":[],"partners":["ARRB1","ARRB2","CANX","PDCD6IP","GNB1","GNAS","AQP2"],"other_free_text":[]},"mechanistic_narrative":"AVPR2 encodes the vasopressin V2 receptor, a Gαs-coupled GPCR that mediates the antidiuretic response in renal collecting duct epithelium by activating adenylyl cyclase/cAMP signaling upon arginine vasopressin binding, thereby promoting AQP2 water channel trafficking to the apical membrane [PMID:16563128, PMID:9171234]. Loss-of-function mutations in AVPR2 cause X-linked nephrogenic diabetes insipidus through mechanisms including ER retention of misfolded receptor (quality-controlled by calnexin) and impaired ligand binding or G protein coupling, while gain-of-function mutations produce constitutive, β-arrestin-independent cAMP signaling and receptor internalization leading to inappropriate antidiuresis [PMID:1303271, PMID:11389590, PMID:26131744, PMID:10820167]. After agonist stimulation, V2R undergoes β-arrestin-dependent internalization into endosomes where the V2R–β-arrestin complex scaffolds Gβγ to regenerate heterotrimeric Gs and sustain endosomal cAMP signaling, while Alix directs V2R to lysosomal degradation [PMID:38972875, PMID:17287200]. The phosphorylation pattern of the V2R C-terminal tail allosterically determines arrestin-2 conformation and biases selective downstream arrestin functions, as revealed by crystal structures of arrestin-2 bound to distinct V2R phosphopeptides [PMID:33888704]."},"prefetch_data":{"uniprot":{"accession":"P30518","full_name":"Vasopressin V2 receptor","aliases":["AVPR V2","Antidiuretic hormone receptor","Renal-type arginine vasopressin receptor"],"length_aa":371,"mass_kda":40.3,"function":"G-protein-coupled receptor for arginine vasopressin, an antidiuretic that promotes renal water reabsorption (PubMed:1534149, PubMed:19440390, PubMed:33664408, PubMed:33742150). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (cAMP) (PubMed:33664408, PubMed:33742150). AVPR2 is coupled to G(s) G alpha proteins and mediates activation of adenylate cyclase activity (PubMed:33664408, PubMed:33742150)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P30518/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AVPR2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/AVPR2","total_profiled":1310},"omim":[{"mim_id":"621542","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 2; ARRDC2","url":"https://www.omim.org/entry/621542"},{"mim_id":"619788","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 4; ARRDC4","url":"https://www.omim.org/entry/619788"},{"mim_id":"618537","title":"ARGININE VASOPRESSIN-INDUCED PROTEIN 1; AVPI1","url":"https://www.omim.org/entry/618537"},{"mim_id":"612464","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 3; ARRDC3","url":"https://www.omim.org/entry/612464"},{"mim_id":"610365","title":"C1q- AND TUMOR NECROSIS FACTOR-RELATED PROTEIN 1; C1QTNF1","url":"https://www.omim.org/entry/610365"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":9.6},{"tissue":"kidney","ntpm":12.5}],"url":"https://www.proteinatlas.org/search/AVPR2"},"hgnc":{"alias_symbol":["V2R"],"prev_symbol":["DIR3","DIR"]},"alphafold":{"accession":"P30518","domains":[{"cath_id":"1.20.1070.10","chopping":"36-237_263-341","consensus_level":"high","plddt":87.0785,"start":36,"end":341}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P30518","model_url":"https://alphafold.ebi.ac.uk/files/AF-P30518-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P30518-F1-predicted_aligned_error_v6.png","plddt_mean":76.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AVPR2","jax_strain_url":"https://www.jax.org/strain/search?query=AVPR2"},"sequence":{"accession":"P30518","fasta_url":"https://rest.uniprot.org/uniprotkb/P30518.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P30518/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P30518"}},"corpus_meta":[{"pmid":"9245589","id":"PMC_9245589","title":"Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, \"minor\" D segments or D-D recombination.","date":"1997","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9245589","citation_count":220,"is_preprint":false},{"pmid":"12628182","id":"PMC_12628182","title":"Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12628182","citation_count":211,"is_preprint":false},{"pmid":"1303271","id":"PMC_1303271","title":"Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus.","date":"1992","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1303271","citation_count":162,"is_preprint":false},{"pmid":"17382427","id":"PMC_17382427","title":"V2R gene families degenerated in primates, dog and cow, but expanded in opossum.","date":"2007","source":"Trends in genetics : TIG","url":"https://pubmed.ncbi.nlm.nih.gov/17382427","citation_count":126,"is_preprint":false},{"pmid":"20399016","id":"PMC_20399016","title":"A comparative study of human health risks via consumption of food crops grown on wastewater irrigated soil (Peshawar) and relatively clean water irrigated soil (lower Dir).","date":"2010","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/20399016","citation_count":126,"is_preprint":false},{"pmid":"8037205","id":"PMC_8037205","title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus.","date":"1994","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8037205","citation_count":125,"is_preprint":false},{"pmid":"16463097","id":"PMC_16463097","title":"Dirigent proteins in conifer defense: gene discovery, phylogeny, and differential wound- and insect-induced expression of a family of DIR and DIR-like genes in spruce (Picea spp.).","date":"2006","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16463097","citation_count":123,"is_preprint":false},{"pmid":"10820168","id":"PMC_10820168","title":"Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus.","date":"2000","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/10820168","citation_count":114,"is_preprint":false},{"pmid":"16024217","id":"PMC_16024217","title":"Composition and evolution of the V2r vomeronasal receptor gene repertoire in mice and rats.","date":"2005","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/16024217","citation_count":111,"is_preprint":false},{"pmid":"18726898","id":"PMC_18726898","title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.","date":"2008","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18726898","citation_count":92,"is_preprint":false},{"pmid":"11389590","id":"PMC_11389590","title":"Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus.","date":"2001","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11389590","citation_count":85,"is_preprint":false},{"pmid":"16229975","id":"PMC_16229975","title":"The gene repertoire and the common evolutionary history of glutamate, pheromone (V2R), taste(1) and other related G protein-coupled receptors.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/16229975","citation_count":72,"is_preprint":false},{"pmid":"22768029","id":"PMC_22768029","title":"DiR-labeled Embryonic Stem Cells for Targeted Imaging of in vivo Gastric Cancer Cells.","date":"2012","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/22768029","citation_count":69,"is_preprint":false},{"pmid":"33888704","id":"PMC_33888704","title":"Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33888704","citation_count":66,"is_preprint":false},{"pmid":"27388755","id":"PMC_27388755","title":"Rapamycin/DiR loaded lipid-polyaniline nanoparticles for dual-modal imaging guided enhanced photothermal and antiangiogenic combination therapy.","date":"2016","source":"Journal of controlled release : official journal of the Controlled Release Society","url":"https://pubmed.ncbi.nlm.nih.gov/27388755","citation_count":63,"is_preprint":false},{"pmid":"7913579","id":"PMC_7913579","title":"Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.","date":"1994","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7913579","citation_count":53,"is_preprint":false},{"pmid":"23150186","id":"PMC_23150186","title":"Hereditary nephrogenic diabetes insipidus in Japanese patients: analysis of 78 families and report of 22 new mutations in AVPR2 and AQP2.","date":"2012","source":"Clinical and experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/23150186","citation_count":47,"is_preprint":false},{"pmid":"10477084","id":"PMC_10477084","title":"MCF-7 breast cancer cells express normal forms of all vasopressin receptors plus an abnormal V2R.","date":"1999","source":"Peptides","url":"https://pubmed.ncbi.nlm.nih.gov/10477084","citation_count":46,"is_preprint":false},{"pmid":"9171234","id":"PMC_9171234","title":"An X-linked NDI mutation reveals a requirement for cell surface V2R expression.","date":"1997","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/9171234","citation_count":43,"is_preprint":false},{"pmid":"16563128","id":"PMC_16563128","title":"Aquaporin 2 (AQP2) and vasopressin type 2 receptor (V2R) endocytosis in kidney epithelial cells: AQP2 is located in 'endocytosis-resistant' membrane domains after vasopressin treatment.","date":"2006","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16563128","citation_count":42,"is_preprint":false},{"pmid":"21112400","id":"PMC_21112400","title":"Coordinated coexpression of two vomeronasal receptor V2R genes per neuron in the mouse.","date":"2010","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/21112400","citation_count":42,"is_preprint":false},{"pmid":"26131744","id":"PMC_26131744","title":"Mutation in the V2 vasopressin receptor gene, AVPR2, causes nephrogenic syndrome of inappropriate diuresis.","date":"2015","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/26131744","citation_count":40,"is_preprint":false},{"pmid":"17005006","id":"PMC_17005006","title":"No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements.","date":"2006","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17005006","citation_count":40,"is_preprint":false},{"pmid":"18951114","id":"PMC_18951114","title":"Vasopressin decreases sepsis-induced pulmonary inflammation through the V2R.","date":"2008","source":"Resuscitation","url":"https://pubmed.ncbi.nlm.nih.gov/18951114","citation_count":37,"is_preprint":false},{"pmid":"17715188","id":"PMC_17715188","title":"Patch-clamp analysis of gene-targeted vomeronasal neurons expressing a defined V1r or V2r receptor: ionic mechanisms underlying persistent firing.","date":"2007","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/17715188","citation_count":35,"is_preprint":false},{"pmid":"20083182","id":"PMC_20083182","title":"Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats.","date":"2010","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/20083182","citation_count":34,"is_preprint":false},{"pmid":"29713336","id":"PMC_29713336","title":"Molecular Characterization, Evolution, and Expression Profiling of the Dirigent (DIR) Family Genes in Chinese White Pear (Pyrus bretschneideri).","date":"2018","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29713336","citation_count":34,"is_preprint":false},{"pmid":"11754100","id":"PMC_11754100","title":"Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus.","date":"2002","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/11754100","citation_count":34,"is_preprint":false},{"pmid":"22144672","id":"PMC_22144672","title":"V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22144672","citation_count":33,"is_preprint":false},{"pmid":"9853256","id":"PMC_9853256","title":"AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.","date":"1998","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/9853256","citation_count":32,"is_preprint":false},{"pmid":"1583663","id":"PMC_1583663","title":"Tandem duplication of the terminal band of the long arm of chromosome 7 (dir dup (7)(q36----qter)).","date":"1992","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1583663","citation_count":31,"is_preprint":false},{"pmid":"20374732","id":"PMC_20374732","title":"V2R mutations and nephrogenic diabetes insipidus.","date":"2009","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/20374732","citation_count":30,"is_preprint":false},{"pmid":"8144963","id":"PMC_8144963","title":"Molecular characterization of human Ig heavy chain DIR genes.","date":"1994","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/8144963","citation_count":30,"is_preprint":false},{"pmid":"30649641","id":"PMC_30649641","title":"Genome-Wide Identification and Characterization of DIR Genes in Medicago truncatula.","date":"2019","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30649641","citation_count":29,"is_preprint":false},{"pmid":"7683452","id":"PMC_7683452","title":"Dir dup(X) (q13-->qter) in a girl with growth retardation, microcephaly, developmental delay, seizures, and minor anomalies.","date":"1993","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7683452","citation_count":29,"is_preprint":false},{"pmid":"10820167","id":"PMC_10820167","title":"Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families.","date":"2000","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/10820167","citation_count":28,"is_preprint":false},{"pmid":"17941907","id":"PMC_17941907","title":"Partial nephrogenic diabetes insipidus caused by a novel mutation in the AVPR2 gene.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17941907","citation_count":27,"is_preprint":false},{"pmid":"8401502","id":"PMC_8401502","title":"A Null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8401502","citation_count":25,"is_preprint":false},{"pmid":"22386940","id":"PMC_22386940","title":"Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.","date":"2012","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/22386940","citation_count":24,"is_preprint":false},{"pmid":"1324225","id":"PMC_1324225","title":"Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1324225","citation_count":23,"is_preprint":false},{"pmid":"27990576","id":"PMC_27990576","title":"Coordinated shift of olfactory amino acid responses and V2R expression to an amphibian water nose during metamorphosis.","date":"2016","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/27990576","citation_count":21,"is_preprint":false},{"pmid":"17229082","id":"PMC_17229082","title":"Urinary pheromones promote ERK/Akt phosphorylation, regeneration and survival of vomeronasal (V2R) neurons.","date":"2006","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17229082","citation_count":21,"is_preprint":false},{"pmid":"7815427","id":"PMC_7815427","title":"Partial trisomy for 2q in a patient with dir dup(2) (q33.1q35).","date":"1994","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7815427","citation_count":21,"is_preprint":false},{"pmid":"33568051","id":"PMC_33568051","title":"Evolution, expression and functional analysis of cultivated allotetraploid cotton DIR genes.","date":"2021","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/33568051","citation_count":20,"is_preprint":false},{"pmid":"29436285","id":"PMC_29436285","title":"Ménière's Disease Pathophysiology: Endolymphatic Sac Immunohistochemical Study of Aquaporin-2, V2R Vasopressin Receptor, NKCC2, and TRPV4.","date":"2018","source":"Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery","url":"https://pubmed.ncbi.nlm.nih.gov/29436285","citation_count":20,"is_preprint":false},{"pmid":"8828987","id":"PMC_8828987","title":"De novo 46,XX, dir dup (11)(q133.3-->q14.2) in a patient with mental retardation, congenital cardiopathy and thrombopenia.","date":"1996","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8828987","citation_count":20,"is_preprint":false},{"pmid":"17318848","id":"PMC_17318848","title":"Contiguous gene deletion involving L1CAM and AVPR2 causes X-linked hydrocephalus with nephrogenic diabetes insipidus.","date":"2007","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/17318848","citation_count":19,"is_preprint":false},{"pmid":"17287200","id":"PMC_17287200","title":"Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R.","date":"2007","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17287200","citation_count":19,"is_preprint":false},{"pmid":"22965914","id":"PMC_22965914","title":"A novel contiguous gene deletion of AVPR2 and ARHGAP4 genes in male dizygotic twins with nephrogenic diabetes insipidus and intellectual disability.","date":"2012","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22965914","citation_count":19,"is_preprint":false},{"pmid":"18845942","id":"PMC_18845942","title":"V1R and V2R segregated vomeronasal pathways to the hypothalamus.","date":"2008","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/18845942","citation_count":18,"is_preprint":false},{"pmid":"22644838","id":"PMC_22644838","title":"Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.","date":"2012","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/22644838","citation_count":18,"is_preprint":false},{"pmid":"8929875","id":"PMC_8929875","title":"Three novel AVPR2 mutations in three Japanese families with X-linked nephrogenic diabetes insipidus.","date":"1996","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/8929875","citation_count":18,"is_preprint":false},{"pmid":"18553546","id":"PMC_18553546","title":"Nephrogenic diabetes insipidus in a patient with L1 syndrome: a new report of a contiguous gene deletion syndrome including L1CAM and AVPR2.","date":"2008","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/18553546","citation_count":18,"is_preprint":false},{"pmid":"28540184","id":"PMC_28540184","title":"Detection of intramyocardially injected DiR-labeled mesenchymal stem cells by optical and optoacoustic tomography.","date":"2017","source":"Photoacoustics","url":"https://pubmed.ncbi.nlm.nih.gov/28540184","citation_count":18,"is_preprint":false},{"pmid":"19217806","id":"PMC_19217806","title":"Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R).","date":"2009","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19217806","citation_count":18,"is_preprint":false},{"pmid":"2729356","id":"PMC_2729356","title":"Direct duplication of chromosome 1, dir dup(1)(p21.2----p32) in a Bedouin boy with multiple congenital anomalies.","date":"1989","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2729356","citation_count":18,"is_preprint":false},{"pmid":"7889648","id":"PMC_7889648","title":"Patient with de novo 12p+ syndrome identified as dir dup (12) (p13) using subchromosomal painting libraries from somatic cell hybrids.","date":"1994","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7889648","citation_count":18,"is_preprint":false},{"pmid":"26715131","id":"PMC_26715131","title":"Nephrogenic syndrome of inappropriate antidiuresis secondary to an activating mutation in the arginine vasopressin receptor AVPR2.","date":"2016","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26715131","citation_count":17,"is_preprint":false},{"pmid":"33024905","id":"PMC_33024905","title":"In silico identification and validation of miRNA and their DIR specific targets in Oryza sativa Indica under abiotic stress.","date":"2020","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/33024905","citation_count":17,"is_preprint":false},{"pmid":"8741911","id":"PMC_8741911","title":"Identification and molecular confirmation of a small chromosome 10q duplication [dir dup(10)(q24.2-->q24.3)] inherited from a mother mosaic for the abnormality.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8741911","citation_count":17,"is_preprint":false},{"pmid":"33009446","id":"PMC_33009446","title":"Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33009446","citation_count":16,"is_preprint":false},{"pmid":"18489790","id":"PMC_18489790","title":"Immunological profile in a family with nephrogenic diabetes insipidus with a novel 11 kb deletion in AVPR2 and ARHGAP4 genes.","date":"2008","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18489790","citation_count":16,"is_preprint":false},{"pmid":"16502494","id":"PMC_16502494","title":"Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations.","date":"2006","source":"Yonsei medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16502494","citation_count":16,"is_preprint":false},{"pmid":"26074997","id":"PMC_26074997","title":"Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure.","date":"2015","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/26074997","citation_count":15,"is_preprint":false},{"pmid":"34486176","id":"PMC_34486176","title":"Pre-clinical evaluation of dual targeting of the GPCRs CaSR and V2R as therapeutic strategy for autosomal dominant polycystic kidney disease.","date":"2021","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/34486176","citation_count":15,"is_preprint":false},{"pmid":"21629670","id":"PMC_21629670","title":"Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor.","date":"2011","source":"NDT plus","url":"https://pubmed.ncbi.nlm.nih.gov/21629670","citation_count":15,"is_preprint":false},{"pmid":"6694186","id":"PMC_6694186","title":"De novo direct tandem duplication of the proximal long arm of chromosome 2: 46,XX,dir dup(2)(q11 X 2q14 X 2).","date":"1984","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/6694186","citation_count":15,"is_preprint":false},{"pmid":"314266","id":"PMC_314266","title":"[Trisomy 13qter by tandem duplication 46, XX, dir dup 13 (q21 qter), 9qh+].","date":"1978","source":"Annales de genetique","url":"https://pubmed.ncbi.nlm.nih.gov/314266","citation_count":15,"is_preprint":false},{"pmid":"12128223","id":"PMC_12128223","title":"Characterization of Dir: a putative potassium inward rectifying channel in Drosophila.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12128223","citation_count":14,"is_preprint":false},{"pmid":"8766937","id":"PMC_8766937","title":"Analysis of vasopressin receptor type II (V2R) gene in three Japanese pedigrees with congenital nephrogenic diabetes insipidus: identification of a family with complete deletion of the V2R gene.","date":"1996","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/8766937","citation_count":14,"is_preprint":false},{"pmid":"22879391","id":"PMC_22879391","title":"Two new large deletions of the AVPR2 gene causing nephrogenic diabetes insipidus and a review of previously published deletions.","date":"2012","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/22879391","citation_count":13,"is_preprint":false},{"pmid":"18701631","id":"PMC_18701631","title":"Regulation of V2R transcription by hypertonicity and V1aR-V2R signal interaction.","date":"2008","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18701631","citation_count":13,"is_preprint":false},{"pmid":"29594432","id":"PMC_29594432","title":"Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus.","date":"2018","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/29594432","citation_count":13,"is_preprint":false},{"pmid":"27601473","id":"PMC_27601473","title":"Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.","date":"2016","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/27601473","citation_count":12,"is_preprint":false},{"pmid":"36406120","id":"PMC_36406120","title":"The barley DIR gene family: An expanded gene family that is involved in stress responses.","date":"2022","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36406120","citation_count":12,"is_preprint":false},{"pmid":"17020465","id":"PMC_17020465","title":"Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.","date":"2006","source":"Genetic testing","url":"https://pubmed.ncbi.nlm.nih.gov/17020465","citation_count":12,"is_preprint":false},{"pmid":"22761946","id":"PMC_22761946","title":"Vasopressin V2R-targeting peptide carrier mediates siRNA delivery into collecting duct cells.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22761946","citation_count":12,"is_preprint":false},{"pmid":"29792162","id":"PMC_29792162","title":"Overlapping but distinct topology for zebrafish V2R-like olfactory receptors reminiscent of odorant receptor spatial expression zones.","date":"2018","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/29792162","citation_count":11,"is_preprint":false},{"pmid":"27329519","id":"PMC_27329519","title":"Fluorescence molecular tomography of DiR-labeled mesenchymal stem cell implants for osteochondral defect repair in rabbit knees.","date":"2016","source":"European radiology","url":"https://pubmed.ncbi.nlm.nih.gov/27329519","citation_count":11,"is_preprint":false},{"pmid":"9016591","id":"PMC_9016591","title":"DIR: a novel DNA rearrangement associated with inverted repeats.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9016591","citation_count":11,"is_preprint":false},{"pmid":"35522082","id":"PMC_35522082","title":"Lamprey possess both V1R and V2R olfactory receptors, but only V1Rs are expressed in olfactory sensory neurons.","date":"2022","source":"Chemical senses","url":"https://pubmed.ncbi.nlm.nih.gov/35522082","citation_count":10,"is_preprint":false},{"pmid":"33850538","id":"PMC_33850538","title":"Anticancer activity of repurposed hemostatic agent desmopressin on AVPR2-expressing human osteosarcoma.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33850538","citation_count":10,"is_preprint":false},{"pmid":"26795631","id":"PMC_26795631","title":"A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.","date":"2016","source":"European journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/26795631","citation_count":10,"is_preprint":false},{"pmid":"37799547","id":"PMC_37799547","title":"Genome-wide identification and expression profiling analysis of DIR gene family in Setaria italica.","date":"2023","source":"Frontiers in plant science","url":"https://pubmed.ncbi.nlm.nih.gov/37799547","citation_count":10,"is_preprint":false},{"pmid":"38972875","id":"PMC_38972875","title":"Role of the V2R-βarrestin-Gβγ complex in promoting G protein translocation to endosomes.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38972875","citation_count":9,"is_preprint":false},{"pmid":"17550212","id":"PMC_17550212","title":"Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.","date":"2007","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/17550212","citation_count":9,"is_preprint":false},{"pmid":"17216256","id":"PMC_17216256","title":"A case of nephrogenic diabetes insipidus with a novel missense mutation in the AVPR2 gene.","date":"2007","source":"Pediatric nephrology (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/17216256","citation_count":9,"is_preprint":false},{"pmid":"30073107","id":"PMC_30073107","title":"Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations.","date":"2018","source":"Case reports in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30073107","citation_count":9,"is_preprint":false},{"pmid":"37680198","id":"PMC_37680198","title":"Genome-wide identification, characterization, evolution and expression analysis of the DIR gene family in potato (Solanum tuberosum).","date":"2023","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37680198","citation_count":9,"is_preprint":false},{"pmid":"33360828","id":"PMC_33360828","title":"DiR-labeled tolerogenic dendritic cells for targeted imaging in collagen- induced arthritis rats.","date":"2020","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33360828","citation_count":9,"is_preprint":false},{"pmid":"34956990","id":"PMC_34956990","title":"Clinical and Functional Characterization of a Novel Mutation in AVPR2 Causing Nephrogenic Diabetes Insipidus in a Four-Generation Chinese Family.","date":"2021","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/34956990","citation_count":8,"is_preprint":false},{"pmid":"31153818","id":"PMC_31153818","title":"Obestatin ameliorates water retention in chronic heart failure by downregulating renal aquaporin 2 through GPR39, V2R and PPARG signaling.","date":"2019","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31153818","citation_count":8,"is_preprint":false},{"pmid":"28165501","id":"PMC_28165501","title":"Therapeutic effects of Euphorbia Pekinensis and Glycyrrhiza glabra on Hepatocellular Carcinoma Ascites Partially Via Regulating the Frk-Arhgdib-Inpp5d-Avpr2-Aqp4 Signal Axis.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28165501","citation_count":8,"is_preprint":false},{"pmid":"27117808","id":"PMC_27117808","title":"A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.","date":"2016","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/27117808","citation_count":8,"is_preprint":false},{"pmid":"3265307","id":"PMC_3265307","title":"Giemsa-11 technique elucidating three structurally altered nonfluorescent Y chromosomes: r (Y), idic (Yp), dir tan dup (Yp).","date":"1988","source":"Annales de genetique","url":"https://pubmed.ncbi.nlm.nih.gov/3265307","citation_count":8,"is_preprint":false},{"pmid":"7868891","id":"PMC_7868891","title":"Recombination potential of the human DIR elements.","date":"1995","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/7868891","citation_count":8,"is_preprint":false},{"pmid":"33721131","id":"PMC_33721131","title":"β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells.","date":"2021","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33721131","citation_count":7,"is_preprint":false},{"pmid":"34101133","id":"PMC_34101133","title":"Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.","date":"2021","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/34101133","citation_count":7,"is_preprint":false},{"pmid":"29472987","id":"PMC_29472987","title":"Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD).","date":"2018","source":"Endocrinology, diabetes & metabolism case reports","url":"https://pubmed.ncbi.nlm.nih.gov/29472987","citation_count":7,"is_preprint":false},{"pmid":"31691500","id":"PMC_31691500","title":"Periconceptional ethanol exposure induces a sex specific diuresis and increase in AQP2 and AVPR2 in the kidneys of aged rat offspring.","date":"2019","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/31691500","citation_count":7,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48545,"output_tokens":3629,"usd":0.100035},"stage2":{"model":"claude-opus-4-6","input_tokens":7110,"output_tokens":3025,"usd":0.166763},"total_usd":0.266798,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"Mutations in AVPR2 (the vasopressin V2 receptor gene at Xq28) cause X-linked nephrogenic diabetes insipidus (NDI), establishing AVPR2 as the gene responsible for renal insensitivity to vasopressin; point mutations resulting in non-conservative amino acid substitutions co-segregated with NDI in affected families.\",\n      \"method\": \"DNA sequencing of AVPR2 in NDI probands; co-segregation analysis in families\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — foundational disease-gene identification replicated across multiple independent labs and hundreds of families\",\n      \"pmids\": [\"1303271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Calnexin, an ER chaperone, associates with both wild-type AVPR2 and NDI-causing mutant receptors (W71X, R337X) during folding; ER-retained mutant R337X showed prolonged calnexin association compared to wild-type, indicating calnexin participates in quality control and ER retention of misfolded AVPR2.\",\n      \"method\": \"Sequential co-immunoprecipitation, immunofluorescence/confocal microscopy, Western blot, RT-PCR, metabolic labeling in transfected cells\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus localization with functional consequence, multiple orthogonal methods in one study\",\n      \"pmids\": [\"11389590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The NDI-associated truncation mutant V2R-R337ter fails to reach the plasma membrane because it is retained as an ER precursor form (endoglycosidase H-sensitive); minimum protein length including residues up to position 341 (and the identity of residue 340) is required for V2R to undergo maturation, acquire cell-surface expression, bind ligand, and couple to adenylyl cyclase.\",\n      \"method\": \"ELISA on epitope-tagged surface receptors, endoglycosidase H treatment, metabolic labeling, adenylyl cyclase activity assay, binding assay in COS.M6/HEK293 cells\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional assays plus glycosylation maturation analysis; rigorous mechanistic dissection with multiple truncation constructs\",\n      \"pmids\": [\"9171234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"After vasopressin stimulation of renal epithelial cells, V2R is rapidly internalized into endosomes while AQP2 remains at the cell surface in 'endocytosis-resistant' membrane domains; V2R endocytosis is independent of cAMP elevation (forskolin does not induce it), and apical vasopressin can induce basolateral V2R down-regulation and vice versa.\",\n      \"method\": \"Confocal live-cell imaging of epitope-tagged V2R and AQP2 in LLC-PK1 cells, fluid-phase endocytosis marker (FITC-dextran) co-localization, polarized cell filter assays\",\n      \"journal\": \"Biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence; multiple orthogonal imaging and pharmacological approaches\",\n      \"pmids\": [\"16563128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Alix (AIP1) interacts with the last 29 amino acids of the V2R C-terminus and increases lysosomal (not proteasomal) degradation of V2R after vasopressin stimulation; overexpression of Alix virtually eliminates V2R-GFP fluorescence within 2 h of vasopressin exposure, an effect blocked by chloroquine but not MG132.\",\n      \"method\": \"Yeast two-hybrid screening, GST pull-down assay, immunolocalization, transfection of Alix into LLC-PK1/V2R-GFP cells, Western blotting with chloroquine/MG132 inhibitors\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — yeast two-hybrid confirmed by pull-down and functional cell assay with pathway-specific inhibitors\",\n      \"pmids\": [\"17287200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Vasopressin reduces LPS-induced pulmonary inflammation (IL-6 levels and NF-κB/phospho-IκB) through the V2R; pretreatment with a V2R-specific antagonist completely abolished vasopressin's immunosuppressive pulmonary effects, placing V2R in an anti-inflammatory signaling pathway in the lung.\",\n      \"method\": \"In vivo mouse sepsis model (LPS), vasopressin infusion with receptor-subtype-selective antagonist pretreatment, immunoblotting for phospho-IκB, ELISA for IL-6\",\n      \"journal\": \"Resuscitation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean pharmacological epistasis with selective antagonist in vivo; single study\",\n      \"pmids\": [\"18951114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"V2R promoter activity is upregulated by hypertonicity via JNK and PKA pathways (10-bp Sp1 motif is the responsive element), and suppressed by V1aR stimulation through a Ca2+ pathway that is further enhanced under hypertonic conditions, demonstrating reciprocal transcriptional regulation between V1aR and V2R signaling.\",\n      \"method\": \"Promoter-reporter assays in LLC-PK1/rV1aR cells, JNK inhibitor (SP600125) and PKA inhibitor (H89) pharmacology, intracellular Ca2+ measurements, deletion analysis of promoter\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter-reporter with mutagenesis and kinase inhibitors; single lab study\",\n      \"pmids\": [\"18701631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Non-peptide V2R antagonists (OPC41061, OPC31260) act as protean agonists: they serve as pharmacological chaperones that rescue membrane trafficking of inactivating V2R mutants (Ser-333del, Y128S) while acting as inverse agonists of wild-type receptor; the trafficking defect of these mutants is not corrected by inhibiting internalization alone.\",\n      \"method\": \"cAMP accumulation assay, immunofluorescence localization in COS-7 cells, pharmacological chaperone rescue experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cAMP assay plus localization rescue in cell culture; single study\",\n      \"pmids\": [\"22144672\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A novel I130N gain-of-function AVPR2 mutation causes constitutive (ligand-independent) cAMP production and constitutive dynamin-dependent, β-arrestin-independent internalization of V2R; agonist-induced endocytosis remained β-arrestin-dependent, revealing mechanistically distinct modes of constitutive vs. agonist-stimulated V2R internalization.\",\n      \"method\": \"cAMP assay in HEK293 cells, dominant-negative dynamin rescue of surface expression, β-arrestin interaction assays, tolvaptan (inverse agonist) inhibition of basal cAMP\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays (cAMP, internalization, dominant-negative rescue) in single study\",\n      \"pmids\": [\"26131744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Crystal structures of arrestin-2 in complex with four different phosphopeptides derived from the V2R C-tail reveal that individual phosphorylation sites allosterically influence arrestin conformation at remote sites; an interdependent phospho-binding mechanism exists between different arrestin phospho-interaction sites, and specific phosphorylation patterns bias arrestin structural states that correlate with selective arrestin functions.\",\n      \"method\": \"X-ray crystallography (four structures), FRET, 1H NMR with genetic code expansion in arrestin-2/V2R phosphopeptide complexes\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures validated by FRET and NMR; multiple orthogonal methods in one study\",\n      \"pmids\": [\"33888704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The V2R–β-arrestin complex scaffolds Gβγ at the plasma membrane through a direct β-arrestin–Gβγ interaction and transports Gβγ to endosomes, where Gβγ potentiates Gαs endosomal translocation, thereby regenerating an endosomal pool of heterotrimeric Gs and enabling sustained endosomal G protein signaling.\",\n      \"method\": \"Co-IP/pulldown demonstrating β-arrestin–Gβγ interaction, live-cell imaging of V2R, β-arrestin, and G protein subunit translocation, functional endosomal cAMP signaling assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct protein interaction plus functional endosomal signaling; single study with multiple complementary approaches\",\n      \"pmids\": [\"38972875\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"dDAVP conjugated to nine D-arginines (dDAVP-9r) binds V2R on inner medullary collecting duct (IMCD) cells and mediates receptor-dependent internalization to deliver siRNA intracellularly; siRNA delivery was specific to V2R-expressing cells and not observed in V2R-negative COS-7 cells, and induced AQP2 phosphorylation at Ser256.\",\n      \"method\": \"siRNA polyplex formation assay, fluorescence microscopy in MDCK/LLC-PK1/COS-7 cells, AQP2 knockdown by Western blot, AQP2 phosphorylation assay in primary IMCD cells\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor-dependent delivery demonstrated by V2R-negative cell controls and functional knockdown; single study\",\n      \"pmids\": [\"22761946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The NDI-causing AVPR2 mutation A84D (near conserved D85) causes intracellular retention of the receptor and severely impairs both ligand binding and G protein coupling, while W99R (first extracellular loop) mainly impairs ligand binding with minor effect on intracellular routing, revealing residue-specific contributions to V2R folding vs. ligand recognition.\",\n      \"method\": \"Radioligand binding assay, adenylyl cyclase coupling assay, immunofluorescence localization in transfected cells\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — binding and coupling assays plus localization; single study with two mutants dissecting distinct functional domains\",\n      \"pmids\": [\"10820167\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Five NDI-causing AVPR2 mutations were functionally characterized: R113Q and C192S localize normally to the basolateral membrane with mature glycosylation; L86P, M272R, and W323_I324insR are retained in the ER with immature glycosylation and reduced stability. Tolvaptan (V2R antagonist/pharmacochaperone) rescued M272R by restoring glycosylation maturation, membrane sorting, and cAMP response to dDAVP.\",\n      \"method\": \"Immunofluorescence localization in polarized MDCK cells, glycosylation maturation (Endo H assay), cAMP release assay, tolvaptan pharmacochaperone rescue\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical and cell biological assays with pharmacochaperone rescue; single study\",\n      \"pmids\": [\"33009446\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AVPR2 (the renal vasopressin V2 receptor) is a G protein-coupled receptor that, upon vasopressin binding, activates Gαs/adenylyl cyclase/cAMP signaling to drive AQP2 trafficking to the apical membrane; ER chaperone calnexin assists V2R folding and performs quality control on misfolded mutants, Alix promotes lysosomal V2R degradation after ligand-stimulated internalization, β-arrestin scaffolds Gβγ to enable endosomal G protein signaling, and the phosphorylation pattern of the V2R C-tail allosterically determines arrestin conformation and selective downstream functions, while gain-of-function mutations cause constitutive cAMP production and β-arrestin-independent internalization leading to inappropriate antidiuresis.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"AVPR2 encodes the vasopressin V2 receptor, a Gαs-coupled GPCR that mediates the antidiuretic response in renal collecting duct epithelium by activating adenylyl cyclase/cAMP signaling upon arginine vasopressin binding, thereby promoting AQP2 water channel trafficking to the apical membrane [PMID:16563128, PMID:9171234]. Loss-of-function mutations in AVPR2 cause X-linked nephrogenic diabetes insipidus through mechanisms including ER retention of misfolded receptor (quality-controlled by calnexin) and impaired ligand binding or G protein coupling, while gain-of-function mutations produce constitutive, β-arrestin-independent cAMP signaling and receptor internalization leading to inappropriate antidiuresis [PMID:1303271, PMID:11389590, PMID:26131744, PMID:10820167]. After agonist stimulation, V2R undergoes β-arrestin-dependent internalization into endosomes where the V2R–β-arrestin complex scaffolds Gβγ to regenerate heterotrimeric Gs and sustain endosomal cAMP signaling, while Alix directs V2R to lysosomal degradation [PMID:38972875, PMID:17287200]. The phosphorylation pattern of the V2R C-terminal tail allosterically determines arrestin-2 conformation and biases selective downstream arrestin functions, as revealed by crystal structures of arrestin-2 bound to distinct V2R phosphopeptides [PMID:33888704].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Identification of AVPR2 as the causative gene for X-linked nephrogenic diabetes insipidus established the molecular basis of renal vasopressin resistance, linking a specific GPCR to water homeostasis.\",\n      \"evidence\": \"DNA sequencing and co-segregation analysis in NDI families\",\n      \"pmids\": [\"1303271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which individual mutations impair receptor function was unknown\", \"No structure–function dissection of critical residues\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that the NDI truncation mutant R337ter is retained in the ER as an immature glycoform incapable of ligand binding or adenylyl cyclase coupling established that the C-terminal tail is essential for V2R maturation and surface trafficking.\",\n      \"evidence\": \"Endoglycosidase H sensitivity, surface ELISA, adenylyl cyclase assay, and truncation series in COS.M6/HEK293 cells\",\n      \"pmids\": [\"9171234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of chaperones involved in ER retention unknown\", \"Structural basis of C-tail requirement unresolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Functional dissection of A84D and W99R mutations revealed that specific residues contribute to distinct steps — protein folding/routing versus ligand recognition — showing that NDI mutations do not act through a single mechanism.\",\n      \"evidence\": \"Radioligand binding, adenylyl cyclase coupling, and immunofluorescence in transfected cells\",\n      \"pmids\": [\"10820167\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only two mutants examined\", \"No structural context for folding versus binding defects\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying calnexin as an ER chaperone that associates with both wild-type and misfolded V2R — with prolonged association for ER-retained mutants — established the molecular basis for ER quality control of V2R.\",\n      \"evidence\": \"Sequential co-immunoprecipitation, confocal microscopy, and metabolic labeling in transfected cells\",\n      \"pmids\": [\"11389590\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether calnexin is sufficient or necessary for retention unknown\", \"Role of other ER quality control components not addressed\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Live-cell imaging revealed that after vasopressin stimulation V2R is rapidly internalized while AQP2 remains at the surface in endocytosis-resistant domains, demonstrating that V2R signaling and V2R endocytosis are temporally uncoupled from the effector (AQP2) response.\",\n      \"evidence\": \"Confocal live-cell imaging with epitope-tagged V2R and AQP2 in polarized LLC-PK1 cells\",\n      \"pmids\": [\"16563128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular identity of 'endocytosis-resistant' AQP2 domains unclear\", \"Mechanism coupling basolateral V2R internalization to apical AQP2 not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Discovery that Alix binds the V2R C-terminus and promotes lysosomal rather than proteasomal degradation after vasopressin stimulation defined the post-endocytic sorting route that terminates V2R signaling.\",\n      \"evidence\": \"Yeast two-hybrid, GST pull-down, and lysosomal/proteasomal inhibitor experiments in LLC-PK1 cells\",\n      \"pmids\": [\"17287200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ESCRT-pathway components downstream of Alix not mapped\", \"Stoichiometry and regulation of Alix–V2R interaction unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Reciprocal transcriptional regulation of AVPR2 by hypertonicity (via JNK/PKA) and V1aR signaling (via Ca²⁺) through a 10-bp Sp1 element revealed how extracellular tonicity and receptor cross-talk control V2R expression levels.\",\n      \"evidence\": \"Promoter-reporter deletion analysis and kinase inhibitors in LLC-PK1 cells\",\n      \"pmids\": [\"18701631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance of V1aR-V2R transcriptional cross-talk unverified\", \"Whether Sp1 itself is the transcription factor binding this element not confirmed by direct binding assay\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showing that non-peptide V2R antagonists rescue surface trafficking of ER-retained NDI mutants while acting as inverse agonists on wild-type receptor established the pharmacological chaperone concept for V2R and its therapeutic potential in NDI.\",\n      \"evidence\": \"cAMP accumulation assay and immunofluorescence rescue in COS-7 cells with OPC41061/OPC31260\",\n      \"pmids\": [\"22144672\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo pharmacochaperone rescue demonstrated in this study\", \"Structural basis for chaperone versus inverse agonist activity unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The gain-of-function I130N mutation revealed that constitutive V2R internalization occurs through a dynamin-dependent but β-arrestin-independent pathway, mechanistically distinct from agonist-stimulated β-arrestin-dependent endocytosis.\",\n      \"evidence\": \"cAMP assay, dominant-negative dynamin, β-arrestin interaction assays in HEK293 cells\",\n      \"pmids\": [\"26131744\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Adaptor mediating constitutive β-arrestin-independent internalization not identified\", \"Only one gain-of-function mutation studied\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Systematic functional characterization of five NDI mutations in polarized cells, including pharmacochaperone rescue of M272R by tolvaptan, confirmed that ER-retained V2R mutants can be functionally rescued to restore both surface expression and cAMP signaling.\",\n      \"evidence\": \"Endo H glycosylation assay, immunofluorescence in polarized MDCK cells, cAMP assay with tolvaptan rescue\",\n      \"pmids\": [\"33009446\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Clinical efficacy of pharmacochaperone therapy not demonstrated\", \"Rescue of R113Q and C192S (surface-expressed but non-functional) not achieved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Crystal structures of arrestin-2 with four distinct V2R C-tail phosphopeptides revealed that specific phosphorylation patterns allosterically determine arrestin conformation at remote sites, providing the structural basis for phosphorylation-barcode-dependent biased signaling.\",\n      \"evidence\": \"X-ray crystallography of four arrestin-2/V2Rpp complexes validated by FRET and ¹H NMR\",\n      \"pmids\": [\"33888704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length V2R–arrestin complex structure not determined\", \"Cellular phosphorylation dynamics at individual sites in native tissue not mapped\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Demonstration that the V2R–β-arrestin complex scaffolds Gβγ and transports it to endosomes to regenerate heterotrimeric Gs established a mechanism for sustained endosomal G protein signaling, resolving how V2R continues cAMP production after internalization.\",\n      \"evidence\": \"Co-IP/pulldown of β-arrestin–Gβγ, live-cell imaging of G protein translocation, endosomal cAMP assays\",\n      \"pmids\": [\"38972875\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of endosomal versus plasma membrane signaling to physiological water reabsorption not quantified\", \"Whether this mechanism operates in collecting duct cells in vivo not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full-length V2R–Gs–β-arrestin megacomplex structure and in vivo quantification of endosomal versus plasma membrane cAMP contributions to the antidiuretic response remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No full-length receptor–arrestin–G protein ternary complex structure exists\", \"In vivo pharmacochaperone efficacy for NDI mutants unestablished in clinical trials driven by structural insights\", \"Native phosphorylation barcode kinetics on V2R in renal tissue not characterized\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 2, 3, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 3, 13]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 2, 13]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3, 10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 7, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"ARRB1\",\n      \"ARRB2\",\n      \"CANX\",\n      \"PDCD6IP\",\n      \"GNB1\",\n      \"GNAS\",\n      \"AQP2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}